These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2786246)

  • 21. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
    Miedema F; Petit AJ; Terpstra FG; Schattenkerk JK; de Wolf F; Al BJ; Roos M; Lange JM; Danner SA; Goudsmit J
    J Clin Invest; 1988 Dec; 82(6):1908-14. PubMed ID: 2974045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HIV infection and T-lymphocyte behavior: results of a study in Palermo].
    Cangelosi C; Giardina RA; Pecoraro G; Marcianò R; Vitale MG; Gullotti A; Caronia F; Spanò C
    Ann Ig; 1989; 1(1-2):45-50. PubMed ID: 2483080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Occurrence of HIV antigens in patients with acquired immunodeficiency syndrome].
    Radkowski M; Laskus T; Kopicz-Kamińska E; Babiuch L; Slusarczyk J
    Pol Arch Med Wewn; 1991 Dec; 86(6):366-71. PubMed ID: 1687897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.
    Masur H; Ognibene FP; Yarchoan R; Shelhamer JH; Baird BF; Travis W; Suffredini AF; Deyton L; Kovacs JA; Falloon J
    Ann Intern Med; 1989 Aug; 111(3):223-31. PubMed ID: 2546472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons].
    Günthard H; Opravil M; Ledergerber B; Olsson K; Vogt M; Fierz W; Lüthy R
    Dtsch Med Wochenschr; 1993 May; 118(20):737-45. PubMed ID: 8099005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1)-infected patients with similar CD4 lymphocyte counts.
    Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
    Am J Epidemiol; 1993 Nov; 138(10):870-8. PubMed ID: 7901990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus infection in sexually active wives of infected hemophilic men.
    Kim HC; Raska K; Clemow L; Eisele J; Matts L; Saidi P; Raska K
    Am J Med; 1988 Oct; 85(4):472-6. PubMed ID: 3177394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrelations of lymphocyte subset values, human immunodeficiency virus antibodies, and HIV antigen levels of homosexual males in San Francisco.
    Krowka JF; Stites DP; Moss AR; Casavant CH; Carlson JR; Chermann JC; Barre-Sinoussi F; Rodgers RP; Bacchetti P; McHugh TM
    Diagn Clin Immunol; 1988; 5(6):381-7. PubMed ID: 3219786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subjects infected with human immunodeficiency virus: serological markers of prognostic value].
    Hurtado C; Velasco M; Sepúlveda C
    Rev Med Chil; 1989 Mar; 117(3):251-7. PubMed ID: 2488516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum and immunological markers of progression to acquired immunodeficiency syndrome in hemophiliacs].
    Navarro MD; Flores JM; Wichmann I; Rey C; Velardo MA; Pineda JA; Leal M; Lissen E
    Med Clin (Barc); 1989 Mar; 92(11):405-8. PubMed ID: 2786123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive markers of AIDS: a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphadenopathy.
    Böttiger B; Morfeldt-Månson L; Putkonen P; Nilsson B; Julander I; Biberfeld G
    Scand J Infect Dis; 1989; 21(5):507-14. PubMed ID: 2511625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictor of the rate of CD4 lymphocyte loss in HIV-1-seropositive asymptomatic hemophiliacs by in vitro immunoglobulin synthesis.
    Cavallin F; Traldi A; di Gaetano R; De Biasi E; Davoli G; Gajo G; Tagariello G; Zambello R
    Clin Immunol Immunopathol; 1996 Dec; 81(3):224-8. PubMed ID: 8938098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets.
    Andrieu JM; Eme D; Venet A; Audroin C; Tourani JM; Stern M; Israel-Biet D; Beldjord K; Driss F; Even P
    Clin Exp Immunol; 1988 Jul; 73(1):1-5. PubMed ID: 3262463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of virus isolation and antigen enzyme immunoassay in the detection of HIV].
    Barrett PN; Dorner F; Stingl G; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1989 Jun; 101(13):446-7. PubMed ID: 2503943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma viremia in human immunodeficiency virus infection.
    Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
    N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell recognition of HIV synthetic peptides in a natural infection.
    Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
    J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.
    Agostini C; Semenzato G; Vinante F; Sinicco A; Trentin L; Zambello R; Zuppini B; Zanotti R; Siviero F; Veneri D
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):146-53. PubMed ID: 2491978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
    Chargelegue D; Colvin BT; O'Toole CM
    AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
    Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
    AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.